Vol.

No.

November 08, 2024Nov 08, 2024

DOWNLOAD THE PDF

What will Trump’s return to the White House mean for oncology? “Our work just got a lot more difficult.”

Cover Story

Editorial

What will Trump’s return to the White House mean for oncology?

“Our work just got a lot more difficult.”

By Paul Goldberg

On Nov. 5, as the American people expressed their will, electing Donald Trump to a second term, I started to wonder what my friends in oncology were thinking.

At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS

By Paul Goldberg

Clinical Trials & Tribulations

A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment

By Otis W. Brawley

Conversation with The Cancer Letter

2024 Harry Hynes Award winner Judith Hopkins on being a doctor in 1977, mentorship, and the benefits of community practice

By Jacquelyn Cobb

Arteaga, Bhardwaj, Coussens, Jagsi, Schrag named members of the National Academy of Medicine

By Jacquelyn Cobb

Free In the Archives

Trump 2016: A look back at the 45th president’s impact on oncology

By Katie Goldberg and Claire Marie Porter

In Brief

Jennifer Bickel named vice president and chief wellness officer at MD Anderson

Lorenzo Galluzzi joins Cancer Signaling and Microenvironment Research Program at Fox Chase

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

UCLA researchers awarded $2.5M grant from BMS Foundation to increase lung cancer screening in underserved communities

MD Anderson’s Boot Walk to End Cancer raises $1.4M

Clinical Roundup

Long-term risks from prostate cancer treatment detailed in new report

Ruxolitinib improves CML’s response to standard TKI treatment

Quitting smoking after a cancer diagnosis improves survival

Survey shows dangerous knowledge gaps in pancreatic cancer

AI may be more accurate vs. traditional methods at classifying patients into prostate cancer risk groups

Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment

Preclinical data show anti-CD24 macrophage checkpoint inhibitor promotes phagocytosis and shrinks tumors

Scientists identify genes that help cancer cells survive in the bloodstream

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Drugs & Targets

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 34 - September 19, 2025